Amid Accusatory Debate, FDA Puts Black Box Warning on Avandia and Actos

| Jul 12, 2007

In a congressional hearing on June 13, 2007, the Food and Drug Administration (FDA) revealed that it has called for a black box warning, the sternest possible, on both Actos and Avandia.

More than a year ago, an FDA drug-safety supervisor recommended that Avandia carry that very warning and was promptly reprimanded for her pains.

After Dr. Nissen's controversial article appeared last month in the New England Journal of Medicine, however, it took the FDA only two days to call for the black box upgrade regarding heart risk.

Throughout the hearing, which was chaired by Democratic Representative Henry Waxman of California, the Democrats criticized the FDA for being lax and the Republicans criticized Dr. Nissen for being inflammatory. Following the contentious meeting, a senior official at GlaxoSmithKline said that the whole issue has been blown out of proportion just so that Democrats can find fault with President Bush's FDA.

During the hearing, a representative of GlaxoSmithKline testified that interim results from the lengthy RECORD trial are reassuring, finding no significant difference in cardiovascular death and heart attack between Avandia takers and control groups.

Apparently both Avandia and Actos are discussing the new warnings with the FDA, in a process that the companies say is supposed to take weeks to months. Since the Nissen report came out last month, Avandia prescriptions have fallen by twenty percent.

Sources: International Herald Tribune
The Wall Street Journal

See "The Latest About Avandia and Actos", August 2007.

Click Here To View Or Post Comments

Categories: Actos, Food, Heart Care & Heart Disease, Pharmacy, Professional Issues, Type 2 Medications


Diabetes Health Professional
Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Latest
Popular
Top Rated
Print | Email | Share | Comments (0)

You May Also Be Interested In...


Comments


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...


Username: Password:
Comment:
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.